Aralez Pharma to enter into purchase agreements to sell substantially all assets
Aralez announced an agreement to sell its VIMOVO® royalties and Canadian operations to Nuvo Pharmaceuticals in a transaction valued at U.S.$110 million and an agreement to sell its TOPROL-XL® Franchise to Deerfield Management Company, L.P., in a transaction valued at U.S.$140 million. August 10, 2018